Hylomorph

Zurich, Switzerland

Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices.

$5.1M raised

Sep 2023

Series B

Top Investors

Verve VenturesZurcher Kantonal BankVenture KickInnosuisseEurostars

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Hylomorph raised?

Hylomorph has raised $5.1M in total funding. The most recent round was Series B. The last funding was announced in September 2023.

Who are Hylomorph's investors?

Hylomorph's investors include Verve Ventures, Zurcher Kantonal Bank, Venture Kick, Innosuisse, Eurostars.

Where is Hylomorph headquartered?

Hylomorph is headquartered in Zurich, Switzerland.

What does Hylomorph do?

Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices.

What stage is Hylomorph at?

Hylomorph is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 5, 2023.

MLA

"Hylomorph — Funding & Investors." VCBacked, September 5, 2023, https://www.vcbacked.co/company/hylomorph. Accessed June 3, 2026.

APA

VCBacked. (2023). Hylomorph — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/hylomorph

Wikipedia (cite web)

{{cite web |title=Hylomorph — Funding & Investors |url=https://www.vcbacked.co/company/hylomorph |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 5, 2023.